Homoharringtonine as a new antileukemic agent.
D000470:Alkaloids / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002681:China; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006248:Harringtonines / Q000009:adverse effects / Q000627:therapeutic use*; D000077863:Homoharringtonine; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D014481:United States
D000470:Alkaloids; D006248:Harringtonines; D000077863:Homoharringtonine